The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene

Oncogene

Volumn 14, Issue 25, 1997, Pages 3099-3102

  Rahman, Nazneen ^a   Arbour, Laura ^b   Tonin, Patricia ^b   Baruchel, Sylvain ^b   Pritchard Jones, Kathryn ^a   Narod, Steven A ^c   Stratton, Michael R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Dominant oncogene; Loss of heterozygosity; Tumour suppressor gene; Wilms' tumour

Indexed keywords

MICROSATELLITE DNA; TUMOR MARKER;

ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CASE REPORT; CHROMOSOME 17Q; FAMILIAL CANCER; FAMILY; GENE LOCATION; GENE MUTATION; GENETIC LINKAGE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; NEPHROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOMES, HUMAN, PAIR 11; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; WILMS TUMOR;

EID: 0030803486     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201107     Document Type: Article

References (31)

1. Biggs PJ, Wooster R, Ford D, Chapman P, Mangion J, Quirk Y, Easton DF, Burn J and Stratton MR. (1995). Nature Genet., 12, 441-443.
2. Breslow NE and Beckwith JB. (1982). J. Natl. Cancer Inst., 68, 429-436.
3. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA Jr, Goodfellow PJ and Donis Keller H. (1994). Proc. Natl. Acad. Sci. USA, 91, 1579-1583.
4. Cavenee WK, Hansen MF, Nordenskjold M, Kock E, Maumenee I and Squire JA. (1985). Science, 228, 501-503.
5. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, Ormiston W, Daly P, Ford D, Easton DF and Stratton MR. (1995). Oncogene, 10, 1673-1675.
6. Donis Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P and Wells SA Jr. (1993). Hum. Mol. Genet., 2, 851-856.
7. Eng C, Mulligan LM, Smith DS, Healey CS, Frilling A, Raue F, Neumann HPH, Pfragner R, Behmel A, Lorenzo MJ, Stonehouse TJ, Ponder MA and Ponder BAJ. (1995). Genes Chrom. Cancer, 12, 209-212.
8. Grundy P, Koufos A, Morgan K, Li FP, Meadows AT and Cavenee WK. (1988). Nature, 336, 374-376.
9. Hemminki A, Peltomaki P, Mecklin J-P, Jarvinen H, Salovaara R, Nystrom-Lahti M, de la Chapelle A and Aaltonen LA. (1994). Nat. Genet., 8, 405-410.
10. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JW, van Amstel HK, Romeo G, et al. (1994). Nature, 367, 375-376.
11. Huff V, Compton DA, Chao LY, Strong LC, Geiser CF and Saunders GF. (1988). Nature, 336, 377-378.
12. Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G, et al. (1992). Cancer Res., 52, 6117-6120.
13. Knudson AG. (1993). Proc. Natl. Acad. Sci. USA, 90, 10914-10921.
14. Landsvater RM, Mathew CG, Smith BA, Marcus EM, te Meerman GJ, Lips CJ, Geerdink RA, Nakamura Y, Ponder BA and Buys CH. (1989). Genomics, 4, 246-250.
15. Legius E, Marchuk DA, Collins FS and Glover TW. (1993). Nat. Genet., 3, 122-126.
16. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B and Kinzler KW. (1994). Cancer Res., 54, 5953-5958.
17. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, et al. (1992). Cancer Res., 52, 3094-3098.
18. Mulligan LM, Gardner E, Smith BA, Mathew CG and Ponder BA. (1993a). Genes Chromosomes Cancer, 6, 166-177.
19. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, et al. (1993b) Nature, 363, 458-460.
20. Nakamura T, Ishizaka Y, Nagao M, Hara M and Ishikawa T. (1994). J. Pathol., 172, 255-260.
21. Nelkin BD, Nakamura Y, White RW, de Bustros AC, Herman J, Wells SA Jr and Baylin SB. (1989). Cancer Res., 49, 4114-4119.
22. Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J and Cowell JK. (1990). Oncogene, 5, 1665-1668.
23. Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, Pritchard-Jones K, Stratton MR and Narod SA. (1996). Nature Genet., 13, 461-463.
24. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, et al. (1995). Science, 267, 381-383.
25. Schwartz CE, Haber DA, Stanton VP, Strong LC, Skolnick MH and Housman DE. (1991). Genomics, 10, 927-930.
26. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamuru H, Latif F, Zbar B, Lerman MI and Yao M. (1994). Cancer Res., 54, 2852-2855.
27. Smith SA, Easton DF, Evans DG and Ponder BAJ. (1992). Nature Genet., 2, 128-131.
28. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merci P, Delattre O, Thomas G and Rouleau GA. (1994). Hum. Mol. Genet., 3, 147-151.
29. Wadey RB, Pal N, Buckle B, Yeomans E, Pritchard J and Cowell JK. (1990). Oncogene, 5, 901-907.
30. Xing S, Smanik PA, Oglesbee MJ, Trosko JE, Mazzaferri EL and Jhiang SM. (1996). Endocrinology, 137, 1512-1519.
31. Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CG and Ponder BA. (1992). Genes Chromosomes Cancer, 4, 337-342.